FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and  

the Drug Safety and Risk Management (DSaRM) Advisory Committee  
FDA White Oak Campus, Building 31, The Great Room (Rm. 1503)  

White Oak Conference Center, Silver Spring, Maryland 

 

 

 

 

June 5-6, 2013 

MEETING ROSTER 

 

Ellen W. Seely, MD 
Professor of Medicine 
Harvard Medical School 
Division of Endocrinology, Diabetes and 
Hypertension  
Brigham and Women’s Hospital 
Boston, MA 

 
ACTING DESIGNATED FEDERAL OFFICER (Non-Voting) 
 
Minh Doan, PharmD 
Division of Advisory Committee & Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE 
MEMBERS (Voting) 
 
Erica H. Brittain, PhD 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious 
Diseases (NIAID) 
National Institutes of Health (NIH) 
Bethesda, MD 
 
David W. Cooke, MD 
Clinical Director, Division of Pediatric 
Endocrinology 
Director, Pediatric Endocrine Fellowship 
Training Program  
Johns Hopkins University School of 
Medicine 
Baltimore, MD 
 
William R. Hiatt, MD, FACP 
Professor of Medicine 
Division of Cardiology 
University of Colorado School of Medicine 
President, Colorado Prevention Center (CPC) 
Clinical Research 
Aurora, CO 
 
 
 

Ida L. Spruill, PhD, RN 
Assistant Professor 
Medical University of South Carolina 
College of Nursing 
Charleston, SC  

Robert J. Smith, MD 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
Ocean State Research Institute 
Providence Veterans Administration Medical 
Center 
Providence, RI  

Page 1 of 5 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and 

 the Drug Safety and Risk Management (DSaRM) Advisory Committee  

 

 

 

 
 

June 5-6, 2013 

MEETING ROSTER (cont.) 

 

ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE 
MEMBERS (Voting) (cont.) 
 
Charles A. Stanley, MD 
Professor of Pediatrics 
Perelman School of Medicine  
University of Pennsylvania  
Division of Endocrinology & Diabetes 
Children’s Hospital of Philadelphia 
Abramson Research Center 
Philadelphia, PA 
 
DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEMBERS 
(Voting) 
 
Marjorie Shaw Phillips, MS, RPh, FASHP 
Pharmacy Coordinator 
Clinical Research and Education 
Georgia Health Sciences Health System 
Clinical Professor of Pharmacy Practice 
University of Georgia College of Pharmacy 
Augusta, GA 
 
INDUSTRY REPRESENTATIVE TO THE COMMITTEE (Non-Voting) 
 
Mads F. Rasmussen, MD, PhD 
Executive Director 
Clinical Development and Research, Diabetes 
Clinical Development 
Medical and Regulatory Affairs 
Novo Nordisk Inc.  
Princeton, NJ 
 
 
 
 
 
 
 

Maria Suarez-Almazor, MD, PhD 
Barnts Family Distinguished Professor  
University of Texas  
MD Anderson Cancer Center 
Houston, TX 
 

Page 2 of 5 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and 

 the Drug Safety and Risk Management (DSaRM) Advisory Committee  

 

 

 

 
 

June 5-6, 2013 

MEETING ROSTER (cont.) 

Dale E. Hammerschmidt, MD, FACP 
Professor of Medicine  
University of Minnesota  
Due Diligence Officer  
(for Human Subjects' Protections)  
Minneapolis, MN 
 
Susan R. Heckbert, MD, PhD 
Professor of Epidemiology 
University of Washington 
Cardiovascular Health Research Unit 
Seattle, WA 
 
Sanjay Kaul, MD  
Director, Fellowship Training Program in  
Cardiovascular Diseases  
Cedars-Sinai Heart Institute  
Professor, David Geffen School of Medicine at 
UCLA  
Division of Cardiology  
Cedar Sinai Medical Center  
Los Angeles, CA 
 
Rebecca Killion  
(Patient Representative)  
Washington, DC 

TEMPORARY MEMBERS (Voting) 
 
CAPT Daniel Budnitz, MD, MPH 
Director, 
Medication Safety Program 
Division of Healthcare Quality Promotion 
Centers for Disease Control and Prevention 
Atlanta, GA 
 
Kenneth D. Burman, MD  
Acting Chairperson 
Chief, Endocrine Section  
Washington Hospital Center  
Washington, DC 

Ruth S. Day, PhD 
Director 
Medical Cognition Laboratory  
Duke University  
Durham, NC 

Eric I. Felner, MD, MSCR 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrinology Fellowship 
Program 
Emory University School of Medicine 
Atlanta, GA 
 
 
 
 
 
 
 

Page 3 of 5 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and 

 the Drug Safety and Risk Management (DSaRM) Advisory Committee  

 

 

 

 
 

June 5-6, 2013 

MEETING ROSTER (cont.) 

TEMPORARY MEMBERS (Voting) (cont.) 
 
Katherine M. Flegal, PhD 
Senior Research Scientist  
Distinguished Consultant  
National Center for Health Statistics, CDC  
Hyattsville, MD  

Nancy L. Geller, PhD  
Director  
Office of Biostatistics Research  
National Heart, Lung and Blood Institute 
NIH  
Bethesda, MD  

Arthur J. Moss, MD 
Professor 
Department of Medicine, Cardiology 
University of Rochester School of Medicine 
Rochester, NY  

David Oakes, PhD 
Professor  
Department of Biostatistics and 
Computational Biology 
University of Rochester 
Rochester, NY 
 

 

Marvin A. Konstam, MD 
Chief Physician Executive 
The Cardiovascular Center 
Tufts Medical Center 
Professor of Medicine 
Tufts University School of Medicine 
Boston, MA 
 
Elaine H. Morrato, DrPH 
Associate Professor 
Department of Health Systems, Management 
and Policy 
University of Colorado, Anschutz Medical 
Campus 
Colorado School of Public Health 
Aurora, CO 
 
Michael A. Proschan, PhD  
Mathematical Statistician  
Biostatistics Research Branch  
NIAID, NIH  
Bethesda, MD 

Gerald van Belle, PhD 
Director, Clinical Trials Center 
Resuscitation Outcome Consortium 
Professor, Departments of Biostatistics and 
Environmental and Occupational Health 
Sciences 
University of Washington 
Seattle, WA 
 
 
 
 
  

Page 4 of 5 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) and 

 the Drug Safety and Risk Management (DSaRM) Advisory Committee  

 

 

 

 
 

June 5-6, 2013 

MEETING ROSTER (cont.) 

TEMPORARY MEMBERS (Voting) (cont.) 
 
T. Mark Woods, PharmD 
Clinical Coordinator and Residency 
Program Director 
Pharmacy Department 
Saint Luke’s Hospital  
Kansas City, MO 
 
FDA PARTICIPANTS (Non-Voting) 
 
Robert J. Temple, MD 
Deputy Director (Acting) 
Office of Drug Evaluation I (ODE-I) 
Office of New Drugs (OND) 
Deputy Director for Clinical Science 
CDER, FDA 
 
John K. Jenkins, MD 
Director 
OND, CDER, FDA 

Curtis J. Rosebraugh, MD, MPH  
Director  
Office of Drug Evaluation II (ODE-II)  
OND, CDER, FDA 
 

Ellis F. Unger, MD 
Director 
ODE-I, OND, CDER, FDA 

 

 

 

Gerald J. Dal Pan, MD, MHS 
Director 
Office of Surveillance and Epidemiology 
(OSE) 
CDER, FDA 

Solomon Iyasu, MD, MPH 
Director 
Office of Pharmacovigilance and 
Epidemiology 
OSE, CDER, FDA 
 
Mary H. Parks, MD  
Director  
Division of Metabolism and Endocrinology 
Products (DMEP), ODE-II, OND 
CDER FDA 
 
Karen M. Mahoney, MD, FACE 
Diabetes Team Leader 
DMEP, ODE-II, OND, CDER, FDA 

Page 5 of 5 

